{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:44:40Z","timestamp":1767494680372,"version":"build-2065373602"},"reference-count":9,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"vor","delay-in-days":10979,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1982,1,2]]},"abstract":"<jats:p>Motion sickness is a common clinical malady. Until recently, the use of scopolamine, the drug of choice for the treatment of motion\u2010induced nausea and vomiting, has been sometimes associated with a variety of unacceptable side effects. These side effects could result from the unpredictable blood levels attained with oral dosage (pulse delivery). A new system of drug delivery, the transdermal therapeutic system (TTS) \u2014 Transderm\u00ae\u2010V \u2014 has been developed. The TTS delivers scopolamine across the skin at a constant rate. This permits a drug with a very short half life to be administered over prolonged periods, thereby maintaining blood concentrations at the defined therapeutic level. This precludes the necessity for frequent dosing and increases patient acceptability and compliance while minimizing the untoward effects associated with conventional dosage forms of the drug.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1982.tb03169.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T08:42:46Z","timestamp":1450255366000},"page":"29-31","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Transdermal Scopolamine in Motion Sickness"],"prefix":"10.1002","volume":"2","author":[{"given":"Carol M.","family":"Cronin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"Sallan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)38129-7"},{"key":"e_1_2_1_3_2","first-page":"310","article-title":"Preliminary reports of trials of antimotion sickness drugs","volume":"21","author":"Bradford WCNW.","year":"1965","journal-title":"Med Serv J Can."},{"key":"e_1_2_1_4_2","first-page":"1096","article-title":"The prevention of experimental motion sickness by scopolamine absorbed through the skin","volume":"47","author":"Graybiel AJ","year":"1976","journal-title":"Aviat Space Environ Med."},{"key":"e_1_2_1_5_2","first-page":"1","article-title":"A review of antimotion sickness drugs from 1954\u20131964","volume":"36","author":"Wood CD","year":"1965","journal-title":"Aerospace Med."},{"key":"e_1_2_1_6_2","first-page":"1108","article-title":"Effect of transdermally administered scopolamine in prevention of motion sickness","volume":"59","author":"McCauley ME","year":"1979","journal-title":"Aviat Space Environ Med."},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(51)91641-8"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)42499-2"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0031-6997(25)07243-6","article-title":"Drugs used in motion sickness","volume":"18","author":"Brand JJ","year":"1966","journal-title":"Pharmacol Rev."},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.57"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1982.tb03169.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1982.tb03169.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1982.tb03169.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:47:02Z","timestamp":1761068822000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1982.tb03169.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,1,2]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1982,1,2]]}},"alternative-id":["10.1002\/j.1875-9114.1982.tb03169.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1982.tb03169.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[1982,1,2]]},"assertion":[{"value":"2012-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}